434 related articles for article (PubMed ID: 22774468)
21. Effect of inhaled toluene diisocyanate on local immune response based on murine model for occupational asthma.
Swierczyńska-Machura D; Nowakowska-Świrta E; Walusiak-Skorupa J; Piasecka-Zelga J; Swiercz R; Nocuń M; Pałczyński C
J Immunotoxicol; 2014; 11(2):166-71. PubMed ID: 23909811
[TBL] [Abstract][Full Text] [Related]
22. Serum cytokines markers in toluene diisocyanate-induced asthma.
Kim JH; Kim JE; Choi GS; Kim HY; Ye YM; Park HS
Respir Med; 2011 Jul; 105(7):1091-4. PubMed ID: 21439806
[TBL] [Abstract][Full Text] [Related]
23. Oropharyngeal aspiration: an alternative route for challenging in a mouse model of chemical-induced asthma.
De Vooght V; Vanoirbeek JA; Haenen S; Verbeken E; Nemery B; Hoet PH
Toxicology; 2009 May; 259(1-2):84-9. PubMed ID: 19428947
[TBL] [Abstract][Full Text] [Related]
24. Frequency and trends of occupational asthma due to toluene diisocyanate: a critical review.
Diller WF
Appl Occup Environ Hyg; 2002 Dec; 17(12):872-7. PubMed ID: 12495598
[TBL] [Abstract][Full Text] [Related]
25. Chemical respiratory allergy and occupational asthma: what are the key areas of uncertainty?
Isola D; Kimber I; Sarlo K; Lalko J; Sipes IG
J Appl Toxicol; 2008 Apr; 28(3):249-53. PubMed ID: 18300327
[TBL] [Abstract][Full Text] [Related]
26. TDI can induce respiratory allergy with Th2-dominated response in mice.
Ban M; Morel G; Langonné I; Huguet N; Pépin E; Binet S
Toxicology; 2006 Jan; 218(1):39-47. PubMed ID: 16271432
[TBL] [Abstract][Full Text] [Related]
27. Diisocyanate asthma: clinical aspects and immunopathogenesis.
Redlich CA; Karol MH
Int Immunopharmacol; 2002 Feb; 2(2-3):213-24. PubMed ID: 11811926
[TBL] [Abstract][Full Text] [Related]
28. T-cell receptor V beta gene segment expression in diisocyanate-induced occupational asthma.
Bernstein JA; Munson J; Lummus ZL; Balakrishnan K; Leikauf G
J Allergy Clin Immunol; 1997 Feb; 99(2):245-50. PubMed ID: 9042053
[TBL] [Abstract][Full Text] [Related]
29. Immunological determinants in a murine model of toluene diisocyanate-induced asthma.
Świerczyńska-Machura D; Walusiak-Skorupa J; Nowakowska-Świrta E; Piasecka-Zelga J; Świercz R; Pałczyński C
Int J Occup Med Environ Health; 2012 Sep; 25(4):492-8. PubMed ID: 23184444
[TBL] [Abstract][Full Text] [Related]
30. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma.
Tee RD; Cullinan P; Welch J; Burge PS; Newman-Taylor AJ
J Allergy Clin Immunol; 1998 May; 101(5):709-15. PubMed ID: 9600510
[TBL] [Abstract][Full Text] [Related]
31. Recent developments in diisocyanate asthma.
Liu Q; Wisnewski AV
Ann Allergy Asthma Immunol; 2003 May; 90(5 Suppl 2):35-41. PubMed ID: 12772950
[TBL] [Abstract][Full Text] [Related]
32. [The response to a specific bronchial provocation test and the evolution of occupational asthma. A longitudinal study in subjects with toluene diisocyanate-induced asthma].
Marabini A; Brugnami G; Curradi F; Severini C; Siracusa A
Med Lav; 1994; 85(2):134-41. PubMed ID: 8072441
[TBL] [Abstract][Full Text] [Related]
33. Biomarkers of toluene diisocyanate exposure.
Brown WE; Burkert AL
Appl Occup Environ Hyg; 2002 Dec; 17(12):840-5. PubMed ID: 12495594
[TBL] [Abstract][Full Text] [Related]
34. Experimental model of asthma by toluene diisocyanate (TDI).
Tanaka K; Kawai M; Maekawa N
Bull Chest Dis Res Inst Kyoto Univ; 1983 Mar; 16(1-2):1-9. PubMed ID: 6317089
[No Abstract] [Full Text] [Related]
35. [The real value of diagnostic methods in case of long time of cessation of occupational exposure to diisocyanates among patients diagnosed in the nofer institute of occupational medicine in Łodź].
Swierczyńska-Machura D; Walusiak-Skorupa J; Wiszniewska M; Lipińska-Ojrzanowska A; Wittczak T; Dudek W; Pałczyński C
Med Pr; 2011; 62(6):567-77. PubMed ID: 22312948
[TBL] [Abstract][Full Text] [Related]
36. Seroimmunological characteristics of Korean workers exposed to toluene diisocyanate.
Kim H; Kim YD; Choi J
Environ Res; 1997 Oct; 75(1):1-6. PubMed ID: 9356188
[TBL] [Abstract][Full Text] [Related]
37. The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma.
Choi JH; Lee KW; Kim CW; Park CS; Lee HY; Hur GY; Kim SH; Hong CS; Jang AS; Park HS
Int Arch Allergy Immunol; 2009; 150(2):156-63. PubMed ID: 19439981
[TBL] [Abstract][Full Text] [Related]
38. Validity of methods to predict the respiratory sensitizing potential of chemicals: A study with a piperidinyl chlorotriazine derivative that caused an outbreak of occupational asthma.
Vanoirbeek JA; Mandervelt C; Cunningham AR; Hoet PH; Xu H; Vanhooren HM; Nemery B
Toxicol Sci; 2003 Dec; 76(2):338-46. PubMed ID: 14514965
[TBL] [Abstract][Full Text] [Related]
39. Occupational asthma diagnosis in workers exposed to organic dust.
Sigsgaard T; Schlunssen V
Ann Agric Environ Med; 2004; 11(1):1-7. PubMed ID: 15236491
[TBL] [Abstract][Full Text] [Related]
40. CD8+ T cell contributions to allergen induced pulmonary inflammation and airway hyperreactivity.
Schaller MA; Lundy SK; Huffnagle GB; Lukacs NW
Eur J Immunol; 2005 Jul; 35(7):2061-70. PubMed ID: 15948214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]